{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:25:39Z","timestamp":1760783139317,"version":"3.44.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":1507,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.virol.2009.03.023","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T04:28:42Z","timestamp":1240460922000},"page":"248-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide"],"prefix":"10.1016","volume":"388","author":[{"given":"S.E.","family":"Altmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schultz-Cherry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.R.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.virol.2009.03.023_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/jop.2006.22.279","article-title":"Corneal toxicity of cell-penetrating peptides that inhibit Herpes simplex virus entry","volume":"22","author":"Akkarawongsa","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.virol.2009.03.023_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1099\/0022-1317-21-3-533","article-title":"The mode of entry of vaccinia virus into L cells","volume":"21","author":"Armstrong","year":"1973","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.virol.2009.03.023_bib5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1086\/428731","article-title":"Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program","volume":"40","author":"Baggs","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"1\u20132","key":"10.1016\/j.virol.2009.03.023_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0166-3542(02)00196-1","article-title":"Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections","volume":"57","author":"Baker","year":"2003","journal-title":"Antiviral. Res."},{"issue":"17","key":"10.1016\/j.virol.2009.03.023_bib7","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1128\/JVI.00852-08","article-title":"Vaccinia virus L1 protein is required for cell entry and membrane fusion","volume":"82","author":"Bisht","year":"2008","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.virol.2009.03.023_bib8","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1128\/JVI.01149-06","article-title":"Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein","volume":"80","author":"Brown","year":"2006","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2009.03.023_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.virol.2003.11.015","article-title":"Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model","volume":"318","author":"Buller","year":"2004","journal-title":"Virology"},{"issue":"39","key":"10.1016\/j.virol.2009.03.023_bib10","doi-asserted-by":"crossref","first-page":"36018","DOI":"10.1074\/jbc.M204849200","article-title":"Peptides containing membrane-transiting motifs inhibit virus entry","volume":"277","author":"Bultmann","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.virol.2009.03.023_bib11","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/JVI.75.6.2634-2645.2001","article-title":"Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1","volume":"75","author":"Bultmann","year":"2001","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2009.03.023_bib12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/AAC.01009-06","article-title":"Addition of a C-terminal cysteine improves the anti-herpes simplex virus activity of a peptide containing the human immunodeficiency virus type 1 TAT protein transduction domain","volume":"51","author":"Bultmann","year":"2007","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"22","key":"10.1016\/j.virol.2009.03.023_bib13","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1128\/JVI.78.22.12147-12156.2004","article-title":"New class of orthopoxvirus antiviral drugs that block viral maturation","volume":"78","author":"Byrd","year":"2004","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2009.03.023_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1099\/vir.0.80831-0","article-title":"Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans","volume":"86","author":"Carter","year":"2005","journal-title":"J. Gen. Virol."},{"issue":"21","key":"10.1016\/j.virol.2009.03.023_bib15","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1001\/jama.294.21.2734","article-title":"Adverse events associated with smallpox vaccination in the United States, January\u2013October 2003","volume":"294","author":"Casey","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.virol.2009.03.023_bib1","unstructured":"Centers for Disease Control (2003a). Update: adverse events following civilian smallpox vaccination\u2014United States, 2003. MMWR Morb Mortal Wkly Rep 52(20), 475\u20137."},{"key":"10.1016\/j.virol.2009.03.023_bib2","unstructured":"Centers for Disease Control (2003b). Update: cardiac-related events during the civilian smallpox vaccination program\u2014United States, 2003. MMWR Morb Mortal Wkly Rep 52(21), 492\u20136."},{"issue":"2","key":"10.1016\/j.virol.2009.03.023_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1099\/0022-1317-32-2-275","article-title":"Further investigations on the mode of entry of vaccinia virus into cells","volume":"32","author":"Chang","year":"1976","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1083\/jcb.18.1.51","article-title":"The uptake and development of vaccinia virus in strain L cells followed with labeled viral deoxyribonucleic acid","volume":"18","author":"Dales","year":"1963","journal-title":"J. Cell. Biol."},{"issue":"3","key":"10.1016\/j.virol.2009.03.023_bib18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0042-6822(64)90167-9","article-title":"The cycle of multiplication of vaccinia virus in Earle's strain L cells I. Uptake and penetration","volume":"24","author":"Dales","year":"1964","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2009.03.023_bib19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0022-2836(89)90107-1","article-title":"Structure of vaccinia virus early promoters","volume":"210","author":"Davison","year":"1989","journal-title":"J. Mol. Biol."},{"issue":"10","key":"10.1016\/j.virol.2009.03.023_bib20","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1128\/jvi.64.10.4884-4892.1990","article-title":"Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane","volume":"64","author":"Doms","year":"1990","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2009.03.023_bib21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/bi00056a008","article-title":"Titration of protein transport activity by incremental changes in signal peptide hydrophobicity","volume":"32","author":"Doud","year":"1993","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.virol.2009.03.023_bib22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.virol.2009.03.023_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virol.2009.03.023_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.291.6.725","article-title":"Tertiary contact vaccinia in a breastfeeding infant","volume":"291","author":"Garde","year":"2004","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0042-6822(90)90381-Z","article-title":"Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein","volume":"178","author":"Gong","year":"1990","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.virol.2009.03.023_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.addr.2004.10.007","article-title":"Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides","volume":"57","author":"Gupta","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.virol.2009.03.023_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/oxfordjournals.jbchem.a021583","article-title":"The hydrophobic region of signal peptides is a determinant for SRP recognition and protein translocation across the ER membrane","volume":"121","author":"Hatsuzawa","year":"1997","journal-title":"J. Biochem."},{"issue":"17","key":"10.1016\/j.virol.2009.03.023_bib28","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1128\/JVI.00624-06","article-title":"The envelope G3L protein is essential for entry of vaccinia virus into host cells","volume":"80","author":"Izmailyan","year":"2006","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.virol.2009.03.023_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01310068","article-title":"Studies on the mechanism of entry of vaccinia virus in animal cells","volume":"92","author":"Janeczko","year":"1987","journal-title":"Arch. Virol."},{"issue":"5","key":"10.1016\/j.virol.2009.03.023_bib30","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1073\/pnas.88.5.1864","article-title":"Antennapedia homeobox peptide regulates neural morphogenesis","volume":"88","author":"Joliot","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"24","key":"10.1016\/j.virol.2009.03.023_bib31","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1128\/JVI.01678-06","article-title":"Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J","volume":"80","author":"Jones","year":"2006","journal-title":"Virol."},{"key":"10.1016\/j.virol.2009.03.023_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1146\/annurev.biochem.70.1.755","article-title":"The signal recognition particle","volume":"70","author":"Keenan","year":"2001","journal-title":"Annu. Rev. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.virol.2009.03.023_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-3542(02)00198-5","article-title":"In vitro activity of potential anti-poxvirus agents","volume":"57","author":"Kern","year":"2003","journal-title":"Antiviral. Res."},{"issue":"6","key":"10.1016\/j.virol.2009.03.023_bib34","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1086\/432765","article-title":"Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted lancy-vaxina vaccine in a single-blind, randomized, prospective trial","volume":"192","author":"Kim","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib35","first-page":"149","article-title":"Membrane cell fusion activity of the vaccinia virus A17\u2013A27 protein complex","volume":"10","author":"Kochan","year":"2008","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.virol.2009.03.023_bib36","first-page":"187","article-title":"Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus","volume":"269","author":"Law","year":"2004","journal-title":"Methods. Mol. Biol."},{"key":"10.1016\/j.virol.2009.03.023_bib37","article-title":"Ligand-induced and nonfusogenic dissolution of a viral membrane","volume":"0601025103","author":"Law","year":"2006","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"24","key":"10.1016\/j.virol.2009.03.023_bib38","doi-asserted-by":"crossref","first-page":"14255","DOI":"10.1074\/jbc.270.24.14255","article-title":"Inhibition of nuclear translocation of transcription factor NF-\u03baB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence","volume":"270","author":"Lin","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.virol.2009.03.023_bib39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/j.1460-2075.1992.tb05199.x","article-title":"The methionine-rich domain of the 54\u00a0kDa subunit of signal recognition particle is sufficient for the interaction with signal sequences","volume":"11","author":"Lutcke","year":"1992","journal-title":"Embo J."},{"issue":"8","key":"10.1016\/j.virol.2009.03.023_bib40","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/AAC.49.8.3153-3162.2005","article-title":"Mechanism of inhibition of vaccinia virus DNA polymerase by cidofovir diphosphate","volume":"49","author":"Magee","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5875","key":"10.1016\/j.virol.2009.03.023_bib41","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1126\/science.1155164","article-title":"Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells","volume":"320","author":"Mercer","year":"2008","journal-title":"Science"},{"issue":"6874","key":"10.1016\/j.virol.2009.03.023_bib42","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/415933a","article-title":"Structural basis for acidic-cluster-dileucine sorting-signal recognition by VHS domains","volume":"415","author":"Misra","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2005.09.037","article-title":"Poxvirus entry and membrane fusion","volume":"344","author":"Moss","year":"2006","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2009.03.023_bib44","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ymthe.2004.08.010","article-title":"Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement","volume":"10","author":"Nakase","year":"2004","journal-title":"Mol. Ther."},{"issue":"1\u20132","key":"10.1016\/j.virol.2009.03.023_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-3542(02)00197-3","article-title":"Therapy and short-term prophylaxis of poxvirus infections: historical background and perspectives","volume":"57","author":"Neyts","year":"2003","journal-title":"Antiviral. Res."},{"issue":"20","key":"10.1016\/j.virol.2009.03.023_bib46","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.1128\/JVI.01035-08","article-title":"The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry","volume":"82","author":"Nichols","year":"2008","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.virol.2009.03.023_bib47","doi-asserted-by":"crossref","first-page":"9822","DOI":"10.1128\/JVI.00987-06","article-title":"Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex","volume":"80","author":"Ojeda","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/JVI.80.1.51-61.2006","article-title":"Entry of vaccinia virus and cell\u2013cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene","volume":"80","author":"Ojeda","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib49","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/jvi.31.1.147-155.1979","article-title":"Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus","volume":"31","author":"Payne","year":"1979","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/jvi.27.1.19-27.1978","article-title":"Adsorption and penetration of enveloped and naked vaccinia virus particles","volume":"27","author":"Payne","year":"1978","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2009.03.023_bib51","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/AAC.50.4.1336-1341.2006","article-title":"Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections","volume":"50","author":"Prichard","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib52","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1074\/jbc.M209548200","article-title":"Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake","volume":"278","author":"Richard","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"RR-10","key":"10.1016\/j.virol.2009.03.023_bib53","first-page":"1","article-title":"Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001","volume":"50","author":"Rotz","year":"2001","journal-title":"MMWR Recomm. Rep."},{"issue":"4","key":"10.1016\/j.virol.2009.03.023_bib54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-4632.2004.02568.x","article-title":"Complications of the smallpox vaccine","volume":"44","author":"Schwartz","year":"2005","journal-title":"Int. J. Dermatol."},{"issue":"8","key":"10.1016\/j.virol.2009.03.023_bib55","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1128\/JVI.79.8.4744-4754.2005","article-title":"Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell\u2013cell fusion","volume":"79","author":"Senkevich","year":"2005","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2009.03.023_bib56","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1128\/JVI.78.5.2357-2366.2004","article-title":"Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene","volume":"78","author":"Senkevich","year":"2004","journal-title":"J. Virol."},{"issue":"51","key":"10.1016\/j.virol.2009.03.023_bib57","doi-asserted-by":"crossref","first-page":"18572","DOI":"10.1073\/pnas.0509239102","article-title":"Poxvirus multiprotein entry-fusion complex","volume":"102","author":"Senkevich","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6874","key":"10.1016\/j.virol.2009.03.023_bib58","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/415937a","article-title":"Structural basis for recognition of acidic-cluster dileucine sequence by GGA1","volume":"415","author":"Shiba","year":"2002","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.virol.2009.03.023_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00199-7","article-title":"A review of compounds exhibiting anti-orthopoxvirus activity in animal models","volume":"57","author":"Smee","year":"2003","journal-title":"Antiviral. Res."},{"issue":"17","key":"10.1016\/j.virol.2009.03.023_bib60","doi-asserted-by":"crossref","first-page":"10988","DOI":"10.1128\/JVI.79.17.10988-10998.2005","article-title":"The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell\u2013cell fusion","volume":"79","author":"Townsley","year":"2005","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.virol.2009.03.023_bib61","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1128\/JVI.79.15.9458-9469.2005","article-title":"Vaccinia virus A21 virion membrane protein is required for cell entry and fusion","volume":"79","author":"Townsley","year":"2005","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.virol.2009.03.023_bib62","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1128\/JVI.01053-06","article-title":"Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway","volume":"80","author":"Townsley","year":"2006","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.virol.2009.03.023_bib63","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1099\/0022-1317-79-4-877","article-title":"Intracellular and extracellular vaccinia virions enter cells by different mechanisms","volume":"79","author":"Vanderplasschen","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-2836(85)90046-4","article-title":"Signal sequences: the limits of variation","volume":"184","author":"von Heijne","year":"1985","journal-title":"J. Mol. Biol."},{"issue":"20","key":"10.1016\/j.virol.2009.03.023_bib65","first-page":"148","article-title":"Declaration of global eradication of smallpox","volume":"55","year":"1980","journal-title":"Weekly Epidemiol. Rec."},{"issue":"1","key":"10.1016\/j.virol.2009.03.023_bib66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bmcl.2004.10.019","article-title":"5\u2032-Homoaristeromycin. Synthesis and antiviral activity against orthopox viruses","volume":"15","author":"Yang","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"20","key":"10.1016\/j.virol.2009.03.023_bib67","doi-asserted-by":"crossref","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge","volume":"79","author":"Yang","year":"2005","journal-title":"J. Virol."},{"issue":"18","key":"10.1016\/j.virol.2009.03.023_bib68","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1111\/j.1742-4658.2005.04777.x","article-title":"Signal peptide hydrophobicity is critical for early stages in protein export by Bacillus subtilis","volume":"272","author":"Zanen","year":"2005","journal-title":"FEBS J."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682209001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682209001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:58:11Z","timestamp":1758585491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682209001998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0042682209001998"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2009.03.023","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2009.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}